Articles dans des revues avec comité de lecture (217)
  1. 168. Rozenberg, S., Barudy Vasquez, J. A., Kroll, M., Twagirayezu, P., Vandromme, J., & Peretz, A. (1998). Pharmaco-économie des traitements de la ménopause : Données épidémiologiques et attitude de prescription hormonale et non hormonale de gynécologues belges. Revue médicale de Bruxelles, 19(4), A195-A198.
  2. 169. Rozenberg, S., Barudy Vasquez, J. A., Vandromme, J., & Kroll, M. (1998). Educating patients about the benefits and drawbacks of hormone replacement therapy. Drugs & aging, 13(1), 33-41.
  3. 170. Praet, J. P., Peretz, A., Mets, T., & Rozenberg, S. (1998). Comparative study of the intestinal absorption of three salts of calcium in young and elderly women. Journal of endocrinological investigation, 21(4), 263-267.
  4. 171. Barudy Vasquez, J. A., Rozenberg, S., Vandromme, J., Kroll, M., Larsimont, D., & Degueldre, M. (1998). Use of heart after treatment for endometrial cancer. International Journal of Fertility and Menopausal Studies, 43(4), 207.
  5. 172. Vandromme, J., Lefever, A., Kroll, M., Paesmans, M., Ham, H., & Rozenberg, S. (1998). Effect of age and bone mineral density on osteoporosis prescription strategies. International Journal of Fertility and Menopausal Studies, 43(4), 214.
  6. 173. Rozenberg, S., Kroll, M., Vandromme, J., Paesmans, M., Lefever, A., & Ham, H. (1997). Factors influencing the prescription of hormone replacement therapy. Obstetrics and gynecology, 90(3), 387-391. doi:10.1016/S0029-7844(97)00268-8
  7. 174. Rozenberg, S., Vandromme, J., & Ham, H. (1997). Facilitating patient-specific decisions regarding hormone replacement therapy. JAMA (Chicago, Ill.), 278(6), 475; author reply 476.
  8. 175. Kaufman, J.-M., Devogelaer, J.-P., Raeman, F., Rozenberg, S., Body, J.-J., Westhovens, R., & Reginster, J.-Y. (1997). Prevention and treatment of postmenopausal osteoporosis. National Consensus of the "Belgian Bone Club", November 1996. Clinical rheumatology, 16(4), 343-345.
  9. 176. Rozenberg, S., Vandromme, J., Kroll, M., Twagirayezu, P., Vyankandondera, J., & Claus, K. (1997). The brittle bone: How to save women from osteoporosis. International journal of fertility and women's medicine, 42(2), 101-106.
  10. 177. Rozenberg, S., Twagirayezu, P., Vyankadondera, J., Hotimsky, A., & Van Rysselberge, M. (1997). Effect of estrogen replacement therapy with or without concomitant nonsteroidal anti-inflammatory drugs on pulsatility and resistance index of uterine arteries in healthy postmenopausal women. International journal of fertility and women's medicine, 42(4), 240-244.
  11. 178. Rozenberg, S., Ylikorkala, O., & Arrenbrecht, S. (1997). Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: Vasomotor symptoms, bleeding patterns, and serum lipids. International journal of fertility and women's medicine, 42(SUPPL. 2), 376-387.
  12. 179. Rozenberg, S., Kroll, M., Vandromme, J., Paesmans, M., & Ham, H. (1996). Effect of bone density evaluation on hormone replacement therapy prescription. Maturitas, 24(1-2), 57-61. doi:10.1016/0378-5122(95)01002-5
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>